Mri-Us Registration Using Label-Driven Weakly-Supervised Learning For Multiparametric Mri-Guided Hdr Prostate Brachytherapy

X. Yang,Q. Zeng,Y. Lei,S. Tian,T. Wang,X. Dong,A. Jani,H. Mao,W.J. Curran,P.R. Patel,T. Liu
DOI: https://doi.org/10.1016/j.ijrobp.2019.06.911
2019-01-01
Abstract:High-dose-rate (HDR) brachytherapy has seen increasing utilization in prostate cancer. Conventional transrectal ultrasound (US)-guided prostate HDR brachytherapy may be enhanced if the dominant intraprostatic lesions (DILs), typically defined by multiparametric MRI (mp-MRI), can also be incorporated into real-time US imaging during catheter placement. In order to enable this integration, we propose a novel MRI-US deformable registration using weakly-supervised deep learning. We propose a weakly-supervised, label-driven, patch-based MRI-US registration framework for learning 3D voxel-wise correspondence from higher-level label correspondence, thereby avoiding conventional intensity-based image similarity measures. A deeply-supervised U-Net was used to label the prostate surfaces on MRI and US images. During training, a convolutional neural network was optimized by generating a dense deformation field (DDF) that deforms a set of available anatomical labels from the MR image to their corresponding US counterparts. These prostate surface label pairs are only required during training and can be spatially aligned by minimizing a logistic loss function of the deformed MRI prostate and the US prostate. During registration prediction, image patch pairs extracted from new MRI and US images were input into the well-trained network to predict an optimal DDF, resulting in a fully automatic, label-free, real-time and deformable registration. The accuracy of our approach was assessed through at several landmarks on the post-registration MRI and US images, and our registration results were compared to a traditional label-driven method. This MRI-US registration was evaluated by leave-one-out cross-validation using 30 datasets from prostate cancer patients who were treated with HDR brachytherapy, each of whom with available MRI and US images. The Dice similarity coefficient (DSC) between deformed MRI and US prostates was 0.85 and 0.90 for the proposed method without and with patch-based learning. The mean target registration error (TRE) was 4.32±0.67 mm for the traditional label-driven method and 2.13±0.35 mm for our proposed method with patch-based learning. We developed a novel MR-US prostate registration approach based on weakly-supervised, label-driven learning. Through MRI-US registration, we could incorporate mp-MRI-defined DILs into real-time US to guide HDR catheter placement. This can improve the probability of achieving the optimal DIL boost delivery, enable accurate boost planning and delivery, and potentially enhance prostate HDR treatment outcomes.
What problem does this paper attempt to address?